相关实验视频

Updated: May 17, 2025

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

鉴定诊断标记物,并建立基于肺癌衍生的外体基因的肺癌预后模型

Yongxiang Zhang¹, Feng Chen², Yuqi Cao²

¹Department of Respiratory and Critical Care Medicine, Tianjin chest Hospital, Tianjin, China.

Cancer biomarkers : section A of Disease markers

|April 3, 2025

概括

这项研究确定了用于肺癌预后的新型外体源基因标记物. 新模型预测了肺腺癌和肺状细胞癌患者的结果,提供了潜在的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
基因组学就是基因组学.

背景情况:

肺癌 (LC) 是全球癌症死亡的主要原因.
来自LC的外体在瘤进展和药物耐药性中起着关键作用.
识别预后标志物对于各种肺癌亚型至关重要.

研究的目的:

为了从肺癌衍生的外基因组中识别预后标志物.
开发肺腺癌 (LUAD),肺状细胞癌 (LUSC) 和其他亚型的预测模型.
评估这些标志物与患者结果的关联.

主要方法:

从GEO和UCSC数据库收集了来自Vesiclependia的外体mRNA数据和来自GEO和UCSC数据库的瘤/癌症组织mRNA数据.
利用单变Cox,LASSO和多变Cox回归分析来建立基于外体体差异表达基因 (ExoDEGs) 的预后模型.
验证了预后值,并分析了与免疫抑制活性的相关性.

主要成果:

开发了一个12-ExoDEG预后模型用于LUAD和一个7-ExoDEG模型用于LUSC.
这两种模型都显示出可靠的预测值,这一点通过生存率和ROC分析得到证实.
在高危人群中,exoDEG表达与免疫抑制活性相关,免疫抑制活性较低.

结论:

通过使用特定的exoDEGs,为LUAD和LUSC建立了可靠的预后模型.
这些模型作为LUAD和LUSC患者的独立预后指标.
已识别的exoDEG显示出作为LUAD和LUSC的预后标记物和治疗点的潜力.

关键词:

生物标志物生物标志物在外基因组中,外基因组是外基因组.肺癌是一种肺癌.预后预后预后风险模型的风险模型.

更多相关视频

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes

Published on: May 24, 2019

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...